| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.006 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.14 | 0.007 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.008 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.008 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.008 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.009 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.2 | 0.01 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.01 |